ESC 365 - Cardiotoxicity evaluation in a patient with recidivant breast cancer and rheumatic heart disease.

ESC Professional Premium Access

Cardiotoxicity evaluation in a patient with recidivant breast cancer and rheumatic heart disease.

Session: Cardio-oncology – Cancer treatment and cardiovascular toxicity

Topic: Cardio-Oncology

Speaker: Doctor A. Issa (Rio de Janeiro, BR)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Aurora Issa

National Institute of Cardiology, Rio de Janeiro (Brazil)

1 presentation

0 follower

4 more presentations in this session

Cardio-oncology – Cancer treatment and cardiovascular toxicity - Get ready for the session.

CAR-T cell induced takotsubo syndrome: a case report.

Speaker: Associate Professor F. Guerra (Ancona, IT)

Multimodality imaging approach in a vascular toxicity case caused by cabozantinib.

Speaker: Doctor G. Benetos (Athens, GR)

Management of doxorubicin-induced cardiomyopathy as the adverse event of chemotherapy in acute critical decompensated heart failure: a case report.

Speaker: Doctor T. Nagai (Kyoto, JP)

Access the full session

Cardio-oncology – Cancer treatment and cardiovascular toxicity

Speakers: Doctor A. Issa, Associate Professor F. Guerra, Doctor G. Benetos, Doctor T. Nagai

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources